New
Image
23.06.2026
Teplizumab, the first treatment to slow type 1 diabetes, approved for ...
The National Institute for Health and Care Excellence (NICE) has approved teplizumab for use on the NHS f...
We take a look at some of the exciting diabetes research developments announced in May 2026, and what the findings could mean for people living with or affected by diabetes.
Read more